Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gabather ABFRA:5J2 14-Day RSI is 48.15 as of Aug. 04, 2026. The stock has 2 warning signs investors should review. Among 1,047 Drug Manufacturers companies, Gabather AB ranks better than 87.3% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-08-04), Gabather AB's 14-Day RSI is 48.15.
The industry rank for Gabather AB's 14-Day RSI or its related term are showing as below:
FRA:5J2's 14-Day RSI is ranked better than 87.3% of 1047
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs FRA:5J2: 48.15
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Gabather AB 14-Day RSI Related Terms
FRA:5J2 vs ZTS, UTHR, VTRS: 14-Day RSI Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Gabather AB's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gabather AB 14-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gabather AB's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Gabather AB's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gabather AB (FRA:5J2) has a 14-Day RSI of 48.15 as of Aug. 04, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Gabather AB and its competitors. According to the industry distribution chart, Gabather AB ranks #133 out of 1047 companies in the Drug Manufacturers industry, placing it in the top 12.7%.
Is Gabather AB's 14-Day RSI too high?
Gabather AB's current 14-Day RSI is 48.15. The Drug Manufacturers industry median 14-Day RSI is 48.44. Gabather AB's value of 48.15 is 0.6% below this industry median. Based on the distribution chart, Gabather AB ranks #133 out of 1047 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Gabather AB's 14-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Gabather AB ranks #133 out of 1047 companies for 14-Day RSI. This places Gabather AB in the top 13% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 48.44. Gabather AB's value of 48.15 is 0.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Drug Manufacturers company?
The median 14-Day RSI among Drug Manufacturers companies is 48.44, based on 1,047 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gabather AB's current 14-Day RSI of 48.15 is 0.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Gabather AB and its competitors. For the Drug Manufacturers industry, the median 14-Day RSI is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gabather AB's current 14-Day RSI is 48.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gabather AB stock overvalued right now?
Gabather AB (FRA:5J2) has a current 14-Day RSI of 48.15. The current 14-Day RSI is 48.15 and 0.6% below the Drug Manufacturers industry median of 48.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Gabather AB (FRA:5J2), the current 14-Day RSI is 48.15 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5J2 has been successfully added to your 
